XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   136,952,000      
Beginning balance at Dec. 31, 2021 $ 1,106,917 $ 137 $ 1,449,305 $ (5,334) $ (337,191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (12,709,000)      
Repurchases of common stock (323,528) $ (13) (323,515)    
Issuance of common stock upon exercise of stock options and ESPP (in shares)   319,000      
Issuance of common stock upon exercise of stock options and ESPP 4,557   4,557    
Net share settlement of equity awards (in shares)   862,000      
Net share settlement of equity awards (12,775) $ 1 (12,776)    
Share-based compensation expense 103,117   103,117    
Other comprehensive income (loss) (96,536)     (96,536)  
Net (loss) income 264,780       264,780
Ending balance (in shares) at Sep. 30, 2022   125,424,000      
Ending balance at Sep. 30, 2022 1,046,532 $ 125 1,220,688 (101,870) (72,411)
Beginning balance (in shares) at Dec. 31, 2021   136,952,000      
Beginning balance at Dec. 31, 2021 $ 1,106,917 $ 137 1,449,305 (5,334) (337,191)
Ending balance (in shares) at Dec. 31, 2022 126,473,827 126,474,000      
Ending balance at Dec. 31, 2022 $ 1,116,589 $ 126 1,244,504 (57,488) (70,553)
Beginning balance (in shares) at Jun. 30, 2022   126,344,000      
Beginning balance at Jun. 30, 2022 818,791 $ 126 1,211,506 (68,868) (323,973)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (1,147,000)      
Repurchases of common stock (23,078) $ (1) (23,077)    
Net share settlement of equity awards (in shares)   227,000      
Net share settlement of equity awards (2,555)   (2,555)    
Share-based compensation expense 34,814   34,814    
Other comprehensive income (loss) (33,002)     (33,002)  
Net (loss) income 251,562       251,562
Ending balance (in shares) at Sep. 30, 2022   125,424,000      
Ending balance at Sep. 30, 2022 $ 1,046,532 $ 125 1,220,688 (101,870) (72,411)
Beginning balance (in shares) at Dec. 31, 2022 126,473,827 126,474,000      
Beginning balance at Dec. 31, 2022 $ 1,116,589 $ 126 1,244,504 (57,488) (70,553)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (13,008,000)      
Repurchases of common stock (186,368) $ (13) (186,355)    
Issuance of common stock upon exercise of stock options and ESPP (in shares)   379,000      
Issuance of common stock upon exercise of stock options and ESPP 3,105   3,105    
Net share settlement of equity awards (in shares)   1,827,000      
Net share settlement of equity awards (13,854) $ 3 (13,857)    
Share-based compensation expense 104,003   104,003    
Proceeds from capped call related to extinguishment of 2025 notes 297   297    
Other comprehensive income (loss) 1,062     1,062  
Net (loss) income $ 8,515       8,515
Ending balance (in shares) at Sep. 30, 2023 115,671,820 115,672,000      
Ending balance at Sep. 30, 2023 $ 1,033,349 $ 116 1,151,697 (56,426) (62,038)
Beginning balance (in shares) at Jun. 30, 2023   115,178,000      
Beginning balance at Jun. 30, 2023 1,035,001 $ 115 1,121,820 (43,179) (43,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and ESPP (in shares)   3,000      
Issuance of common stock upon exercise of stock options and ESPP 26   26    
Net share settlement of equity awards (in shares)   491,000      
Net share settlement of equity awards (2,788) $ 1 (2,789)    
Share-based compensation expense 32,640   32,640    
Other comprehensive income (loss) (13,247)     (13,247)  
Net (loss) income $ (18,283)       (18,283)
Ending balance (in shares) at Sep. 30, 2023 115,671,820 115,672,000      
Ending balance at Sep. 30, 2023 $ 1,033,349 $ 116 $ 1,151,697 $ (56,426) $ (62,038)